The Nipah virus is endemic in sporadic and seasonally clustered outbreaks across South and Southeast Asia, with confirmed cases reported in West Bengal, India and Bangladesh in early 2026. To date, no officially approved specific therapeutics for the Nipah virus have been developed worldwide.
Initial symptoms include fever, headache, fatigue, vomiting and diarrhea, which are highly similar to those of influenza or the common cold, leading to a high risk of misdiagnosis.
In the severe stage, the disease progresses rapidly to viral encephalitis (characterized by impaired consciousness, epilepsy and coma) and severe pneumonia (manifested as dyspnea and hypoxemia), which can trigger multiple organ failure.
Prognosis: The case fatality rate ranges from 40% to 75%. Approximately one-fifth of survivors suffer from long-term neurological sequelae such as cognitive impairment, epilepsy and limb weakness.
The harm of the Nipah virus stems from pulmonary infection, with the most severe damage inflicted on the cranial nerves. The Herbal Order has conducted in-depth research on the Nipah virus, and its formulated herbal prescriptions can effectively control the virus, significantly reduce the mortality rate and improve the cure rate.
Free Download The Herbal Order Formula